UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Journal of clinical oncology, 2008-02, Vol.26 (4), p.633-638

2008

Volltextzugriff (PDF)

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2545-2551

2012

Volltextzugriff (PDF)

Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study

Journal of clinical oncology, 2009-05, Vol.27 (15), p.2536-2541

2009

Volltextzugriff (PDF)

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group

Pediatric blood & cancer, 2016-01, Vol.63 (1), p.54-61

2016

Volltextzugriff (PDF)

Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1574-1580

2003

Volltextzugriff (PDF)

Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group

Clinical cancer research, 2010-08, Vol.16 (15), p.4024-4030

2010

Volltextzugriff (PDF)

Multiple Drug Resistance in Osteogenic Sarcoma: INT0133 From the Children's Oncology Group

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2057-2062

2007

Volltextzugriff (PDF)

Current Treatment of Osteosarcoma

Cancer investigation, 2001, Vol.19 (3), p.292-315

2001

Volltextzugriff (PDF)

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Journal of clinical oncology, 2005-03, Vol.23 (9), p.2004-2011

2005

Volltextzugriff (PDF)

Intensive Therapy With Growth Factor Support for Patients With Ewing Tumor Metastatic at Diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457—A Report From the Children's Oncology Group

Journal of clinical oncology, 2006-01, Vol.24 (1), p.152-159

2006

Volltextzugriff (PDF)

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: A pediatric oncology group trial

Journal of clinical oncology, 2002-01, Vol.20 (2), p.426-433

2002

Volltextzugriff (PDF)

Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer

The New England journal of medicine, 1995-06, Vol.332 (26), p.1738-1744

1995

Volltextzugriff (PDF)

Ototoxicity in children treated for osteosarcoma

Pediatric Blood & Cancer, 2009-03, Vol.52 (3), p.387-391

2009

Volltextzugriff (PDF)

Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial

Journal of clinical oncology, 2002-01, Vol.20 (2), p.426-433

Goorin, A. M.

2002

Volltextzugriff (PDF)

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma

Cancer, 2003-08, Vol.98 (4), p.832-840

2003

Volltextzugriff (PDF)

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Journal of clinical oncology, 2015-07, Vol.33 (20), p.2279-2287

2015

Volltextzugriff (PDF)

Monitoring for anthracycline cardiotoxicity

Pediatrics (Evanston), 1994-03, Vol.93 (3), p.433-437

1994

Volltextzugriff (PDF)

Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial

Journal of pediatric hematology/oncology, 2001-08, Vol.23 (6), p.340-348

2001

Volltextzugriff (PDF)

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

The New England journal of medicine, 1986-06, Vol.314 (25), p.1600-1606

1986

Volltextzugriff (PDF)

Ovarian toxicity after chemotherapy: Possible association with ifosfamide administration

Pediatric Blood & Cancer, 2004-03, Vol.42 (3), p.216-219

2004

Volltextzugriff (PDF)

Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: A children's oncology group study

Pediatric blood & cancer, 2014-04, Vol.61 (4), p.749-752

2014

Volltextzugriff (PDF)

Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study

Journal of clinical oncology, 1998-11, Vol.16 (11), p.3641-3648

1998

Volltextzugriff (PDF)

Osteosarcoma: fifteen years later

The New England journal of medicine, 1985-12, Vol.313 (26), p.1637-1643

1985

Volltextzugriff (PDF)

Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer

The Journal of pediatrics, 1990, Vol.116 (1), p.144-147

1990

Volltextzugriff (PDF)

In Reply

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4860-4861

2007

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(36)
Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Female
(27)
Oncology
(26)
Male
(25)
Adolescent
(24)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Child
(23)
Osteosarcoma - Drug Therapy
(21)
Adult
(19)
Bone Neoplasms - Drug Therapy
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Child, Preschool
(15)
Pharmacology. Drug Treatments
(14)
Bone Neoplasms - Mortality
(13)
Antineoplastic Agents
(11)
Doxorubicin - Administration & Dosage
(11)
Osteosarcoma - Mortality
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group

Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651

Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group

Multiple Drug Resistance in Osteogenic Sarcoma: INT0133 From the Children's Oncology Group

Current Treatment of Osteosarcoma

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Intensive Therapy With Growth Factor Support for Patients With Ewing Tumor Metastatic at Diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457—A Report From the Children's Oncology Group

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: A pediatric oncology group trial

Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer

Ototoxicity in children treated for osteosarcoma

Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Monitoring for anthracycline cardiotoxicity

Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

Ovarian toxicity after chemotherapy: Possible association with ifosfamide administration

Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: A children's oncology group study

Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study

Osteosarcoma: fifteen years later

Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer

In Reply

Suchergebnisse filtern